[1] 余欢,牛国超,李风华,等.系统性红斑狼疮相关性胰腺炎诊治进展[J].胃肠病学和肝病学杂志,2023,32(2):235-237. [2] Fukaya S,Yasuda S,Hashimot T,et al.Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases:analysis of 30 cases[J].Rheumatology(Oxford),2008,47(11):1686-1691. [3] Gerstein M,Borgia RE,Dominguez,et al.Predicting macrophage activation syndrome in childhood-onset systemic lupus erythematosus patients at diagnosis[J].Rheumatology,2021,48(9):1450-1457. [4] Cohen EM,Sliva KD,Kreps D,et al.Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus[J].Lupus,2018,27(7):1065-1071. [5] 牛梦亚,文礼.病理性钙信号与急性胰腺炎[J].中华胰腺病杂志,2022,22(1):22-29. [6] Yarkac A,Kose A,Bozkurt BS,et al.The value of hematological parameters in acute pancreatitis[J].Ulus Travma Acil Cerrahi Derg,2019,25(5):453-460. [7] 张丽娇,黎晓琴,刘红,等.血清淀粉酶及肝损伤相关指标在急性胰腺炎病情评估中的应用[J].分子诊断与治疗杂志,2023,15(1):141-144. [8] 彭凯新,文礼.急性胰腺炎的发病机制研究进展及未来展望[J].西安交通大学学报(医学版),2024,45(2):167-177. [9] 柯瑶,吕成银,宣文华,等.HScore评分在结缔组织病合并巨噬细胞活化综合征诊断中的应用价值[J].中华风湿病学杂志,2020,24(12):826-829. [10] 王琦,谈文峰.结缔组织病相关噬血细胞综合征的诊治[J].临床血液学杂志,2023,36(1):10-15. [11] Minoia F,Bovis F,Davi S,et al.Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis[J].Ann Rheum Dis,2019,78(10):1357-1362. [12] Allen CE,Yu XY,Kozinetz CA,et al.Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis[J].Pediatric Blood Cancer,2008,50(6):1227-1235. [13] Wormsbecker AJ,Sweet DD,Mann SL,et al.Conditions associated with extreme hyperferritinemia (>3000μg/L) in adults[J].Internal Medicine Journal,2015,45(8):828-833. [14] 陈洋,张文静,闫薛,等.继发性噬血细胞综合征患者临床特征及外周血检查指标与疗效的关系[J].白血病.淋巴瘤, 2018, 27(11):5. [15] 赵磊,卢波兰,詹卓,等.61例噬血细胞综合征临床预后影响因素[J].内科急危重症杂志,2023,29(5):406-408. |